Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 11, 2024

High-Efficacy Therapy Discontinuation vs Continuation in Patients Aged 50 Years or Older With Nonactive MS

JAMA Neurology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Neurology
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
JAMA Neurol 2024 Mar 25;[EPub Ahead of Print], G Jouvenot, G Courbon, M Lefort, F Rollot, R Casey, E Le Page, L Michel, G Edan, J de Seze, L Kremer, K Bigaut, S Vukusic, G Mathey, J Ciron, A Ruet, E Maillart, P Labauge, H Zephir, C Papeix, G Defer, C Lebrun-Frenay, T Moreau, DA Laplaud, E Berger, B Stankoff, P Clavelou, E Thouvenot, O Heinzlef, J Pelletier, A Al-Khedr, O Casez, B Bourre, P Cabre, A Wahab, L Magy, JP Camdessanché, I Doghri, S Moulin, H Ben-Nasr, C Labeyrie, K Hankiewicz, JP Neau, C Pottier, C Nifle, N Collongues, A Kerbrat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading